MORNEAU MICHAEL 4
4 · Viking Therapeutics, Inc. · Filed Apr 3, 2020
Insider Transaction Report
Form 4
MORNEAU MICHAEL
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2020-03-31+15,000→ 15,000 totalExercise: $4.68From: 2021-03-31Exp: 2030-03-31→ Common Stock (15,000 underlying)
Footnotes (1)
- [F1]25% of the shares subject to the option will vest on each anniversary of the grant date.